PRESS RELEASE published on 10/20/2023 at 18:45, 2 years 1 month ago EQS-Adhoc: Cardea Europe AG: Annual General Meeting approves the resolutions proposed by the Management Board and Supervisory Board on all agenda items
PRESS RELEASE published on 10/20/2023 at 18:45, 2 years 1 month ago EQS-Adhoc: Cardea Europe AG: Bondholders resolve restructuring of the bond 2020/2023
PRESS RELEASE published on 09/28/2023 at 17:35, 2 years 2 months ago EQS-Adhoc: Invitation to vote without a meeting of the bondholders of the 7.25% bond 2020/2023 of Cardea Europe AG
PRESS RELEASE published on 08/15/2023 at 17:37, 2 years 3 months ago Cardea Europe AG: Cardea Europe AG to be acquired by Cardea Luna Capital Partners LTD., establishes global fintech financing platform
PRESS RELEASE published on 08/15/2023 at 17:35, 2 years 3 months ago EQS-Adhoc: Cardea Europe AG: Acquisition by affiliated entity Cardea Luna Capital Partners LTD.
PRESS RELEASE published on 05/19/2023 at 07:00, 2 years 6 months ago CARDEA EUROPE NOTES STABILITY AMIDST RECENT BOND PRICE MOVEMENT
Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
